Circio Holding ASA
CRNA | OL
Overview
Corporate Details
- ISIN(s):
- NO0012858564 (+5 more)
- LEI:
- 5967007LIEEXZXFYNS31
- Country:
- Norway
- Address:
- Vollsveien 19, 1366 Lysaker
- Website:
- https://www.targovax.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Circio Holding ASA (OSE: CRNA) is a biotechnology company developing novel circular RNA and immunotherapy medicines. Circio Holding ASA is a biotechnology company developing novel circular RNA and immunotherapy medicines. Circio has established a unique circular RNA (circRNA) platform to develop novel circRNA medicines for rare disease, vaccines, and cancer. The proprietary circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA and viral vectors, which can be deployed for many purposes. The circVec platform has demonstrated enhanced and more durable protein expression than classic mRNA vector systems, and has the potential to become the new gold-standard for DNA and virus-based therapeutics in the future. The circRNA R&D activities are being conducted by the wholly owned subsidiary Circio AB based at the Karolinska Institute in Stockholm, Sweden.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-06 09:53 |
Capital/Financing Update
Circio Holding ASA: Registration of share capital increase following conversion…
|
English | 2.7 KB | |
| 2025-06-05 13:49 |
Declaration of Voting Results & Voting Rights Announcements
Circio Holding ASA: Minutes from the annual general meeting 2025 - Attachment: …
|
English | 870.6 KB | |
| 2025-06-05 13:49 |
Declaration of Voting Results & Voting Rights Announcements
Circio Holding ASA: Minutes from the annual general meeting 2025
|
English | 2.9 KB | |
| 2025-06-04 22:00 |
Capital/Financing Update
Circio Holding ASA: Requested Conversion of Convertible Bonds
|
English | 3.5 KB | |
| 2025-05-28 07:00 |
Investor Presentation
Circio presents new and differentiating circVec data and corporate update in li…
|
English | 2.7 MB | |
| 2025-05-28 07:00 |
Regulatory News Service
Circio presents new and differentiating circVec data and corporate update in li…
|
English | 6.0 KB | |
| 2025-05-27 15:35 |
Proxy Solicitation & Information Statements
Circio Holding ASA - Updated information to the notice of annual general meetin…
|
English | 120.7 KB | |
| 2025-05-27 15:35 |
Share Issue/Capital Change
Circio Holding ASA - Updated information to the notice of annual general meetin…
|
English | 4.2 KB | |
| 2025-05-22 05:00 |
Report Publication Announcement
Circio invites to R&D and corporate update webcast on 28 May 2025
|
English | 2.2 KB | |
| 2025-05-15 13:30 |
Regulatory News Service
Circio Holding ASA - Notice of annual general meeting 2025
|
Norwegian | 1.6 MB | |
| 2025-05-15 13:30 |
Regulatory News Service
Circio Holding ASA - Notice of annual general meeting 2025
|
Norwegian | 2.7 KB | |
| 2025-05-15 10:19 |
Capital/Financing Update
Circio Holding ASA: Registration of share capital increase following conversion…
|
English | 2.7 KB | |
| 2025-05-15 06:07 |
Major Shareholding Notification
Atlas Holdings for CIRCIO
|
English | 760 bytes | |
| 2025-05-14 06:11 |
Major Shareholding Notification
Atlas Holdings for CIRCIO
|
English | 732 bytes | |
| 2025-05-13 23:00 |
Inside Information Statement
Circular RNA innovator Circio presents strengthened circVec gene therapy data a…
|
English | 1.9 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
| Hiron-Trade Investments & Industrial Buildings Ltd. | Israel | HRON | ||
|
Human Stem Cells Institute PJSC | Russian Federation | ISKJ | |
|
Human Xtensions Ltd. | Israel | HUMX | |
|
Hybrigenics SA | France | ALHYG | |
|
Hyloris Pharmaceuticals SA | Belgium | HYL | |
|
Ikonisys S.A. | France | ALIKO | |
|
IMCB PJSC | Russian Federation | GEMA | |
|
Inify Laboratories AB | Sweden | INIFY | |
|
Innate Pharma | France | IPH | |
|
IntegraGen | France | ALINT |